Answers are grounded in this paper and cite their sources.
Analysis shows reduced tumor growth and inflammation in lung cancer models with RORγt inhibition, suggesting a therapeutic potential.
Supplementary Figure S4. The proliferation and viability of LUAD cell lines are unaffected by RORγ/γt pharmacological inhibition or Rorc genetic deletion.
No takes yet. Share an insight, caveat, or question.
Yamada‐Hara et al. (2025) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: